Factor Therapeutics announced that Rosalind Wilson has completed her tenure as Chief Executive Officer and been retained, on a part-time consulting basis, to assist with progressing the company's future plans. Dr. Wilson joined Factor Therapeutics in mid-2017, overseeing completion of the Phase 2 clinical programme in venous leg ulcer healing and the limited expansion of the Company's pipeline.